Hepatocellular Carcinoma
Conditions
Interventions
case group:Nil
Sponsors
Zhongshan Hospital of Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Clinical or pathological diagnosis of hepatocellular carcinoma; 2. Patients with hepatocellular carcinoma who could not be surgically removed, were not suitable / intolerant to or failed to TACE, were treated with HAIC; 3. At least one measurable target lesion; 4. ECOG score 0-2; 5. The state of liver function was child Pugh A or B; 6. Life expectancy is at least 3 months; 7. Male or female patients aged from 18 to 85 years; 8. Requirements for bone marrow function, liver function and renal function of patients: (1)Hemoglobin concentration > 85 g/L; (2)Peripheral blood WBC > 3 x 10^9/L; (3)Platelet count >= 50 x 10^9/L; (4)Total bilirubin concentration = 28 g / L; (6)Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) <= 5 ULN; (7)Prothrombin time international normalized ratio < 2.3 ULN; (8)Serum creatinine <= 1.5 ULN; (9)Lipase and amylase <= 2 ULN.
Exclusion criteria
Exclusion criteria: 1.History of previous or concurrent other tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progress Free Survival;Objective Response Rate;AFP response;Disease Control Rate; | — |
Countries
China
Contacts
Public ContactChen Rongxin
Zhongshan Hospital of Fudan University
Outcome results
None listed